Cdk Inhibition in Human Cells Compromises Chk1 Function and Activates a DNA Damage Response
Shannon L. Maude(Children's Hospital of Philadelphia), Greg H. Enders(Community Health Systems - Moses Taylor Hospital)
Cited by 58
Related Papers
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
|Blood|2015|718
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
|Nature Reviews Clinical Oncology|2022|324